- Home
- AUTL vs IBEX Comparison
AUTL vs IBEX Comparison
Compare AUTL & IBEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AUTL | IBEX |
|---|---|---|
| Founded | 2014 | 2017 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 433.8M | 386.9M |
| IPO Year | 2018 | 2020 |
Fundamental Metrics
Financial Performance| Metric | AUTL | IBEX |
|---|---|---|
| Price | $1.67 | $38.47 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 3 |
| Target Price | $8.33 | ★ $31.33 |
| AVG Volume (30 Days) | ★ 2.4M | 85.3K |
| Earning Date | 11-12-2025 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 46.76 |
| EPS | N/A | ★ 2.77 |
| Revenue | $51,128,000.00 | ★ $579,735,000.00 |
| Revenue This Year | $669.49 | $12.15 |
| Revenue Next Year | $91.53 | $5.68 |
| P/E Ratio | ★ N/A | $13.91 |
| Revenue Growth | ★ 406.67 | 12.86 |
| 52 Week Low | $1.11 | $20.18 |
| 52 Week High | $2.80 | $42.99 |
Technical Indicators
Market Signals| Indicator | AUTL | IBEX |
|---|---|---|
| Relative Strength Index (RSI) | 57.88 | 60.72 |
| Support Level | $1.63 | $37.75 |
| Resistance Level | $1.79 | $39.30 |
| Average True Range (ATR) | 0.09 | 0.92 |
| MACD | 0.01 | 0.21 |
| Stochastic Oscillator | 59.09 | 73.13 |
Price Performance
Historical ComparisonAbout AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About IBEX IBEX Limited
IBEX Ltd delivers innovative business process outsourcing (BPO), smart digital marketing, online acquisition technology, and end-to-end customer engagement solutions to help companies acquire, engage, and retain valuable customers. It is an end-to-end provider of technology-enabled customer lifecycle experience (CLX) solutions to optimize customer acquisition, engagement, expansion, and experience for its clients. IBEX operates through the Business process outsourcing segment. Its services cover three areas: Digital and omni-channel Customer Experience (ibex Connect), Digital Marketing and E-Commerce (ibex Digital) and Digital CX surveys and analytics (ibex CX). It caters to a broad range of industries, such as telecommunications, cable, financial services, and healthcare.